UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. ブルガダ症候群：予後、マネージメント、スクリーニング検査方法brugada syndrome prognosis management and approach to screening [show details]
… of the screening process for the majority of patients. Because of relatively limited data regarding the best approach to screening in such patients, recommendations for screening in this… therapy with a subcutaneous ICD system may reduce the risk of lead complications,…
- 2. 透析患者に生じやすい心疾患のスクリーニングと診断の概要overview of screening and diagnosis of heart disease in dialysis patients [show details]
… we suggest that patients receiving dialysis undergo screening for heart disease . In each dialysis patient, screening is performed to determine the presence… patients compared with the general population. In an analysis of data from United States Renal Data System (USRDS), the HF hospitalization rate (with HF as a primary reason for hospitalization) in 2011 for …
- 3. 神経系の腫瘍随伴性症候群の概要overview of paraneoplastic syndromes of the nervous system [show details]
… but otherwise exclusively expressed by the nervous system , or rarely by the nervous system and testes . For unknown reasons, the immune system identifies these antigens as… cancer screening in three to six months after an initial negative evaluation, followed by screening every six months up until four years, if testing remains unrevealing . In LEMS, screening for two…
- 4. RhD 型不適合妊娠の概要overview of rhd alloimmunization in pregnancy [show details]
… antibody screen should be performed at the first prenatal visit. For D-negative women with an initially negative antibody screen and uncomplicated pregnancy, the antibody screen is repeated at… key clinical issues related to the Rhesus system. A detailed discussion of the Rhesus system,…
- 5. 産褥期の概要：生理学的変化、合併症、母体のケアoverview of the postpartum period physiology complications and maternal care [show details]
… with guidelines from multiple organizations, we screen all women for postpartum depression. Programs that combine screening and adequate support systems improve clinical outcomes in pregnant and postpartum …
Related Links
- 薬剤学Vol. 74, No. 5 (2014) 323 は，求められる時期に結果が間に合わないことが懸 念される．マンパワーも不足する．また，創薬段階 においては，製剤検討に利用できる化合物量に制約 がある．開発段階が初期であればあるほど，これら
- LC/MS/MS分析において必要となる分離条件の検討や各化合物に対するMS パラメータの最適化などの煩雑な作業をユーザーが実施することなく分析をはじめることができるため，多成分一斉分析業務の効率化に有効です。
- マテリアルズインフォマティクス業務におけるIT活用ポイント 自動車、エネルギー、医療などのあらゆる分野で医薬品、化学品、触媒、ポリマー、電池燃料などにおける高性能な材料開発は、豊かな社会を実現する上で重要となります。
Related Pictures
★リンクテーブル★
[★]
- 英
- automated multiphasic health testing system
- 同
- AMHTシステム AMHT system、多項目健診システム、多相式スクリーニングシステム
- 関
- AMHT
[★]
- 英
- equation、formula、formulae、expression、Eq.
- 関
- 公式、処方箋、発現、表現、表情、方程式、発現量
[★]
- 英
- system
- 関
- 系、体系、体制、方式
[★]
- 英
- multiphasic、polyphasic
- 関
- 多相性